Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.51
-0.21 (-1.43%)
Apr 25, 2025, 10:39 AM EDT - Market open
Arcutis Biotherapeutics Employees
Arcutis Biotherapeutics had 342 employees as of December 31, 2024. The number of employees increased by 46 or 15.54% compared to the previous year.
Employees
342
Change (1Y)
46
Growth (1Y)
15.54%
Revenue / Employee
$574,684
Profits / Employee
-$409,471
Market Cap
1.72B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ARQT News
- 6 days ago - Arcutis Opportunity To Capitalize On Leadership, Pipeline, And Commercial Assets - Seeking Alpha
- 8 days ago - Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - GlobeNewsWire
- 14 days ago - Arcutis Announces Chief Financial Officer Transition - GlobeNewsWire
- 20 days ago - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Arcutis and Padagis Agree to Stay Patent Lawsuit - GlobeNewsWire
- 4 weeks ago - Arcutis to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 7 weeks ago - Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting - GlobeNewsWire